What does this research mean for the field?

Whole-exome sequencing combined with scalable bioinformatics analysis can successfully identify the genetic etiology of hearing loss in a large, heterogeneous population even when clinical records are incomplete. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate whether high-throughput whole-exome sequencing coupled with electronic medical record biobank data can identify pathogenic variants and novel candidate genes in hearing loss patients lacking detailed clinical histories.

September 5, 2026Journal of Medical GeneticsOpen Access

Exome sequencing and large-scale analysis of electronic medical record-linked biobank data identify candidate deafness genes

View Full Paper

Ask AI

Bookmark

Authors

ZBZippora Brownstein LKLara Kamal YZYazeed Zoabi

Discussion

Member takes

Overview

Biobank cohort study uncovers genetic diagnoses and novel candidate genes in hearing-impaired patients, highlighting the utility of scalable exome analysis despite incomplete medical records.

Key Points

To evaluate whether high-throughput whole-exome sequencing coupled with electronic medical record biobank data can identify pathogenic variants and novel candidate genes in hearing loss patients lacking detailed clinical histories.
Analyzed DNA samples from 1,038 hearing-impaired individuals enrolled in the Maccabi Research and Innovation Center Tipa Biobank using whole-exome sequencing.
Extracted clinical audiograms from electronic medical records, noting the absence of onset age and inheritance patterns.
Implemented a scalable bioinformatics pipeline to annotate, filter, and prioritize variants across the cohort despite incomplete clinical documentation.
Solved or potentially solved 15% of hearing loss cases using known or novel variants in established deafness genes.
Identified homozygous variants in novel candidate genes in 3% of cases, followed by functional characterization to confirm inner-ear relevance.

Cite This Study

Brownstein et al. (2026) studied this question.

synapsesocial.com/papers/6a9bd4726b95aff0620ec343 https://doi.org/10.1136/jmg-2026-111784

View Full Paper

Ask AI

Bookmark

September 5, 2026Journal of Medical GeneticsOpen Access

Exome sequencing and large-scale analysis of electronic medical record-linked biobank data identify candidate deafness genes

View Full Paper

Ask AI

Bookmark

Authors

ZBZippora Brownstein LKLara Kamal YZYazeed Zoabi

Discussion

Member takes

Overview

Biobank cohort study uncovers genetic diagnoses and novel candidate genes in hearing-impaired patients, highlighting the utility of scalable exome analysis despite incomplete medical records.

Key Points

To evaluate whether high-throughput whole-exome sequencing coupled with electronic medical record biobank data can identify pathogenic variants and novel candidate genes in hearing loss patients lacking detailed clinical histories.
Analyzed DNA samples from 1,038 hearing-impaired individuals enrolled in the Maccabi Research and Innovation Center Tipa Biobank using whole-exome sequencing.
Extracted clinical audiograms from electronic medical records, noting the absence of onset age and inheritance patterns.
Implemented a scalable bioinformatics pipeline to annotate, filter, and prioritize variants across the cohort despite incomplete clinical documentation.
Solved or potentially solved 15% of hearing loss cases using known or novel variants in established deafness genes.
Identified homozygous variants in novel candidate genes in 3% of cases, followed by functional characterization to confirm inner-ear relevance.

Cite This Study

Brownstein et al. (2026) studied this question.

synapsesocial.com/papers/6a9bd4726b95aff0620ec343 https://doi.org/10.1136/jmg-2026-111784

View Full Paper

Ask AI

Bookmark